Corrigendum to: The role of medications in causing dry eye (Journal of Ophthalmology (2018) 2018 (7396982) DOI: 10.1155/2012/285851);The role of medications in causing dry eye

Journal of Ophthalmology

Volumn 2012, Issue , 2012, Pages

  Fraunfelder, Frederick T ^a   Sciubba, James J ^b   Mathers, William D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Milton J Dance Jr Head and Neck Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873827287     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2019/2989680     Document Type: Erratum

References (43)

1. Sullivan B. D., Whitmer D., Nichols K. K., Tomlinson A., Foulks G. N., Geerling G., Pepose J. S., Kosheleff V., Porreco A., Lemp M. A., An objective approach to dry eye disease severity. Investigative Ophthalmology and Visual Science 2010 51 12 6125 6130 2-s2.0-79951910364 10.1167/iovs.10-5390
2. Nichols K. K., Foulks G. N., Bron A. J., Glasgow B. J., Dogru M., Tsubota K., Lemp M. A., Sullivan D. A., The international workshop on meibomian gland dysfunction: executive summary. Investigative Ophthalmology and Visual Science 2011 52 4 1922 1929 2-s2.0-79953736441 10.1167/iovs.10-6997a
3. Foulks G. N., Bron A. J., Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. The Ocular Surface 2003 1 3 107 126 2-s2.0-0842283842 (Pubitemid 41263900)
4. Zhou S., Li Y., Lu A. T. H., Liu P., Tang M., Yiu S. C., Huang D., Reproducibility of tear meniscus measurement by Fourier-domain optical coherence tomography: a pilot study. Ophthalmic Surgery Lasers and Imaging 2009 40 5 442 447 2-s2.0-70449723394 10.3928/15428877-20090901-01
5. Kaufman P. L., Alm A., Adler F. H., Adler's Physiology of the Eye: Clinical Application 2003 10th St. Louis, Mo, USA Mosby
6. Berkovitz B. K. B., Holland G. R., Moxham B. J., Oral Anatomy, Histology and Embryology 2009 4th New York, NY, USA Mosby/Elsevier
7. Sreebny L. M., Schwartz S. S., A reference guide to drugs and dry mouth-2nd edition. Gerodontology 1997 14 1 33 47 2-s2.0-0031174975 10.1111/j.1741-2358.1997.00033.x
8. Schein O. D., Hochberg M. C., Muñoz B., Tielsch J. M., Bandeen-Roche K., Provost T., Anhalt G. J., West S., Dry eye and dry mouth in the elderly: a population-based assessment. Archives of Internal Medicine 1999 159 12 1359 1363 2-s2.0-0033612546 10.1001/archinte.159.12.1359 (Pubitemid 29293598)
9. Guggenheimer J., Moore P. A., Xerostomia: etiology, recognition and treatment. Journal of the American Dental Association 2003 134 1 61 69 2-s2.0-0442293648 (Pubitemid 38186298)
10. Moss S. E., Klein R., Klein B. E. K., Long-term incidence of dry eye in an older population. Optometry and Vision Science 2008 85 8 668 674 2-s2.0-52049113514 10.1097/OPX.0b013e318181a947
11. Moss S. E., Klein R., Klein B. E. K., Prevalance of and risk factors for dry eye syndrome. Archives of Ophthalmology 2000 118 9 1264 1268 2-s2.0-0033624389
12. Schaumberg D. A., Dana R., Buring J. E., Sullivan D. A., Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Archives of Ophthalmology 2009 127 6 763 768 2-s2.0-66949164787 10.1001/archophthalmol.2009.103
13. Fraunfelder F. T., Fraunfelder F. W., Chambers W. A., Clinical Ocular Toxicology 2008 Elsevier Saunders
14. PDR Staff, Physicians'Desk Reference 2010 64th Montvale, NJ, USA PDR Network, LLC
15. Foulks G. N., 2007 Report of the international dry eye workshop (DEWS). The Ocular Surface 2007 5 2 65 204 2-s2.0-46149120139
16. Slabaugh S. L., Maio V., Templin M., Abouzaid S., Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs & Aging 2010 27 12 1019 1028 2-s2.0-78649349306 10.2165/11584990-000000000-00000
17. Gu Q., Dillon C. F., Burt V. L., Prescription drug use continues to increase: US prescription drug data for 2007-2008. NCHS Data Brief 2010 42 1 8 2-s2.0-79952116174
18. Fraunfelder F. T., Gilbaugh J. H., Retire Right: 8 Scientifically Proven Traits You Need for a Happy, Fulfilling Retirement 2008 New York, NY, USA Penguin
19. Osterberg T., Landahl S., Hedegard B., Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women. Correlation to dental health, dryness in the mouth, disease and drug treatment. Journal of Oral Rehabilitation 1984 11 2 157 170 2-s2.0-0021146360
20. Loesche W. J., Bromberg J., Terpenning M. S., Bretz W. A., Dominguez B. L., Grossman N. S., Langmore S. E., Xerostomia, xerogenic medications and food avoidances in selected geriatric groups. Journal of the American Geriatrics Society 1995 43 4 401 407 2-s2.0-0028942485
21. Persson R. E., Izutsu K. T., Truelove E. L., Persson R., Differences in salivary flow rates in elderly subjects using xerostomatic medications. Oral Surgery, Oral Medicine, Oral Pathology 1991 72 1 42 46 2-s2.0-0025784919
22. Sreebny L. M., Valdini A., Yu A., Xerostomia. Part II: relationship to nonoral symptoms, drugs, and diseases. Oral Surgery, Oral Medicine, Oral Pathology 1989 68 4 I 419 427 2-s2.0-0024401242 (Pubitemid 19254442)
23. Rybacki J. J., Long J. W., The Essential Guide To Prescription Drugs 1996 New York, NY, USA Harper Perennial
24. Edwards I. R., Biriell C., Harmonisation in pharmacovigilance. Drug Safety 1994 10 2 93 102 2-s2.0-0028049067 (Pubitemid 24045719)
25. Fechtner R. D., Godfrey D. G., Budenz D., Stewart J. A., Stewart W. C., Jasek M. C., Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010 29 6 618 621 2-s2.0-77952956785 10.1097/ICO.0b013e3181c325b2
26. Rossi G. C. M., Tinelli C., Pasinetti G. M., Milano G., Bianchi P. E., Dry eye syndrome-related quality of life in glaucoma patients. European Journal of Ophthalmology 2009 19 4 572 579 2-s2.0-68149132520
27. Pflugfelder S. C., Antiinflammatory therapy for dry eye. American Journal of Ophthalmology 2004 137 2 337 342 2-s2.0-1242316166 10.1016/j.ajo.2003.10.036 (Pubitemid 38221009)
28. Baudouin C., Garcher C., Haouat N., Bron A., Gastaud P., Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 1994 101 3 454 460 2-s2.0-0028263028 (Pubitemid 24100569)
29. Baudouin C., Liang H., Hamard P., Riancho L., Creuzot-Garcher C., Warnet J. M., Brignole-Baudouin F., The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008 115 1 109 115 2-s2.0-37449007089 10.1016/j.ophtha.2007.01.036
30. Viso E., Gude F., Rodríguez-Ares M. T., The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea 2011 30 1 1 6 2-s2.0-78650950370 10.1097/ICO.0b013e3181da5778
31. Hay E. M., Thomas E., Pal B., Hajeer A., Chambers H., Silman A. J., Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: results from a population based study. Annals of the Rheumatic Diseases 1998 57 1 20 24 2-s2.0-0031899338 (Pubitemid 28175215)
32. Schein O. D., Hochberg M. C., Muñoz B., Tielsch J. M., Bandeen-Roche K., Provost T., Anhalt G. J., West S., Dry eye and dry mouth in the elderly: a population-based assessment. Archives of Internal Medicine 1999 159 12 1359 1363 2-s2.0-0033612546 10.1001/archinte.159.12.1359 (Pubitemid 29293598)
33. Leung E. W., Medeiros F. A., Weinreb R. N., Prevalence of ocular surface disease in glaucoma patients. Journal of Glaucoma 2008 17 5 350 355 2-s2.0-57149134057 10.1097/IJG.0b013e31815c5f4f
34. Fellman R. L., Sullivan E. K., Ratliff M., Silver L. H., Whitson J. T., Turner F. D., Weiner A. L., Davis A. A., Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial. Ophthalmology 2002 109 5 998 1008 2-s2.0-0036236701 10.1016/S0161-6420(02)01010-2 (Pubitemid 34465238)
35. Cohen J. S., Gross R. L., Cheetham J. K., VanDenburgh A. M., Bernstein P., Whitcup S. M., Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Survey of Ophthalmology 2004 49 2, supplement 1 S45 S52 2-s2.0-1542328115 10.1016/j.survophthal.2003.12.019 (Pubitemid 38317486)
36. Alm A., Camras C. B., Watson P. G., Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States. Survey of Ophthalmology 1997 41 supplement 2 S105 S110 2-s2.0-0031003948 (Pubitemid 27154533)
37. Baudouin C., Labbé A., Liang H., Pauly A., Brignole-Baudouin F., Preservatives in eyedrops: the good, the bad and the ugly. Progress in Retinal and Eye Research 2010 29 4 312 334 2-s2.0-77953359918 10.1016/j.preteyeres.2010. 03.001
38. Jaenen N., Baudouin C., Pouliquen P., Manni G., Figueiredo A., Zeyen T., Ocular symptoms and signs with preserved and preservative-free glaucoma medications. European Journal of Ophthalmology 2007 17 3 341 349 2-s2.0-34447129594 (Pubitemid 47056287)
39. Broadway D. C., Grierson I., O'Brien C., Hitchings R. A., Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Archives of Ophthalmology 1994 112 11 1446 1454 2-s2.0-0028021073 (Pubitemid 24350507)
40. Kashkouli M. B., Rezaee R., Nilforoushan N., Salimi S., Foroutan A., Naseripour M., Topical antiglaucoma medications and lacrimal drainage system obstruction. Ophthalmic Plastic and Reconstructive Surgery 2008 24 3 172 175 2-s2.0-45549087583 10.1097/IOP.0b013e3181706829
41. Seider N., Miller B., Beiran I., Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction. American Journal of Ophthalmology 2008 145 1 120 123 2-s2.0-37249087174 10.1016/j.ajo.2007.07.033 (Pubitemid 350265745)
42. Schwab I. R., Linberg J. V., Gioia V. M., Benson W. H., Chao G. M., Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 1992 99 2 197 202 2-s2.0-0026511512
43. Thorne J. E., Anhalt G. J., Jabs D. A., Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 2004 111 1 45 52 2-s2.0-0346157379 10.1016/j.ophtha.2003.03.001 (Pubitemid 38032209)